BOULDER, Colo., May 9, 2018 /PRNewswire/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer,
Ron Squarer, will speak at the Bank
of America Merrill Lynch 2018 Health Care Conference in
Las Vegas. The public is welcome
to participate in the conference through a webcast on the Array
BioPharma website.
|
Event:
|
Bank of America
Merrill Lynch 2018 Health Care Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer, Array BioPharma
|
|
Date:
|
Wednesday, May 16,
2018
|
|
Time:
|
8:40 a.m. Pacific
Time
|
|
Webcast:
|
http://www.veracast.com/webcasts/baml/healthcare2018/id01202184563.cfm
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer and other conditions. Ten
registration studies are currently advancing related to eight
Array-owned or partnered drugs: encorafenib (LGX818), binimetinib
(MEK162), ARRY-797, selumetinib (partnered with AstraZeneca),
danoprevir (partnered with Roche), ipatasertib (partnered with
Genentech), larotrectinib (partnered with Loxo Oncology) and
tucatinib (partnered with Seattle Genetics). For more information
on Array, please go to www.arraybiopharma.com.
CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate
Communications
(303) 381-6600
ir@arraybiopharma.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-2018-health-care-conference-300645764.html
SOURCE Array BioPharma